It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Washington state and the city of Seattle on Thursday joined more than two dozen other government entities across the country suing to hold opioid makers accountable for an addiction crisis that has claimed thousands of lives. The governments hope to recoup costs of responding to drug addiction, including money spent on emergencies, criminal justice and social services.
originally posted by: watchitburn
a reply to: CB328
I would be on board with this as long as the monetary awards don't go directly to the junkies or their families.
They should go to education and after school programs and stuff like that.
originally posted by: iWontGiveUP
originally posted by: DBCowboy
a reply to: CB328
When are they going to sue Hershey's for making me fat?
I blame left twix
Right Twix is ok
Mayor Ray Stephanson tells CBS Seattle affiliate KIRO-TV the city will seek reimbursement from Purdue Pharma for tens of millions of dollars the city has spent responding to overdoses and drug-related crimes. “Purdue Pharmaceuticals was knowingly putting OxyContin into the black market in our community,” Stephanson said.
The city also alleges the company did not stop its pills from being diverted to illegal traffickers, who sold them in Everett between 2007 and 2010, when OxyContin was reformulated to prevent abuse.
“Once that drug was not available, those who had gotten addicted turned to heroin and today you can get a bag of heroin on the street for five bucks,” Stephanson said.
One in 12 doctors has received money from drug companies marketing prescription opioid medications, according to a study released Wednesday afternoon. Researchers at Boston Medical Center found that from 2013 to 2015, 68,177 doctors received more than $46 million in payments from drug companies pushing powerful painkillers. Researchers believe it is the first study to look at the practice of pharmaceutical companies marketing opioids to physicians.